Basic Information
Basic information for MIR9-3HG-202-28aa
Peptide Name MIR9-3HG-202-28aa
Genome Position chr15:89395624-89395707[+]
Species Human
Peptide Sequence MLLCCCQGSTEADLSYAGKRPSLSKCLR
Peptide Length 28
Unique No (MIR9-3HG-201-28aa,MIR9-3HG-203-28aa,MIR9-3HG-205-28aa,MIR9-3HG-212-28aa,MIR9-3HG-213-28aa,MIR9-3HG-214-28aa,MIR9-3HG-218-28aa,MIR9-3HG-219-28aa,MIR9-3HG-220-28aa,MIR9-3HG-221-28aa,MIR9-3HG-222-28aa,MIR9-3HG-224-28aa,MIR9-3HG-225-28aa,MIR9-3HG-226-28aa,MIR9-3HG-227-28aa,MIR9-3HG-228-28aa,MIR9-3HG-229-28aa,MIR9-3HG-233-28aa,MIR9-3HG-240-28aa,MIR9-3HG-241-28aa,MIR9-3HG-242-28aa,MIR9-3HG-244-28aa,MIR9-3HG-246-28aa-1,MIR9-3HG-247-28aa,MIR9-3HG-248-28aa,MIR9-3HG-249-28aa,MIR9-3HG-251-28aa,MIR9-3HG-252-28aa,MIR9-3HG-253-28aa)
Grand Average of Hydropathicity -0.0143
Relative Molecular Mass 3521.02
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000538734;MIR9-3HG-202
Transcript Length 1867
Coding Ability 0.481
DNA Sequence Corresponding to Peptide ATGCTGCTGTGCTGTTGCCAGGGGAGCACGGAGGCAGATCTGAGCTATGCAGGGAAAAGGCCCAGCCTGTCAAAGTGTCTGAGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :